HCG - 5000iu
For research purposes only – no human use.
HCG - 5000iu is supplied strictly as a laboratory research peptide for analytical and scientific use only. Available to qualified researchers, laboratories, and institutions in Perth and across Western Australia, with Australian-based fulfilment.
Intended for in-vitro research, assay development, method validation, and controlled scientific investigation conducted by appropriately qualified professionals.
Product details
- Product: Thymosin Alpha
- Molecular Formula: C11H19N3O6S
- Strength / size: 500iu
- Category: Research peptide / laboratory compound
- Use: Laboratory research only
- Certification: Certificate of Analysis (COA) / batch documentation (where available)
- Supply: Perth & Western Australia (AU shipping)
- Packaging: Secure, discreet packaging
HCG 5000iu (Human Chorionic Gonadotropin)
Human chorionic gonadotropin (hCG) is a hormone produced by trophoblast tissue, which is typically found in early embryos and eventually develops into part of the placenta. Measuring hCG levels can help distinguish between normal and abnormal pregnancies and is also useful for monitoring after a pregnancy loss. In addition, hCG testing can aid in the diagnosis of certain cancers, such as choriocarcinoma and some extra-uterine malignancies.
The human chorionic gonadotropin (hCG) is recognized as a term that describes 4 separate isoforms, each with a distinct biological function and produced by a different type of cell within the body. These include synthesis from villous syncytiotrophoblasts, multiple primary nontrophoblastic malignancies or tumors, the anterior pituitary gland, and cytotrophoblast cells. The principal functions of hCG synthesized from villous syncytiotrophoblastic cells include promoting progesterone production by the corpus luteal cells and subsequent growth of cytotrophoblast cells. The actions of hCG allow a coordinated growth of the fetus and uterus, signal the endometrium of impending implantation, support the growth and differentiation of the umbilical cord, and promote fetal growth and organogenesis.
Hyperglycosylated forms of hCG from cytotrophoblastic cells promote growth and invasion of these cells, thus contributing to the pathogenesis of choriocarcinoma cells. A similar mechanism can occur in hCG-free beta-subunits synthesized by nontrophoblastic tumors. The detection of the free-beta subunit hCG is suggestive of malign cancer and poor prognosis. hCG synthesized by the anterior pituitary gland is produced at low levels throughout the menstrual cycle and mimics the luteinizing hormone (LH) effects.
***Our 2026 Janoshik testing has commenced. New COA’s will be updated shortly